Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 8, 1998

View Archived Issues

Company Profile: Advanced Magnetics

Viragen: Q1 1998 highlights

BTG: six-month highlights

Company Profile: IDEA

Senju reports synthesis and evaluation of compounds with multiple pharmacological actions

Australian university scientists design new diflunisal esters with improved characteristics

Adenosine kinase inhibitors and methods of use described by Abbott

Water-soluble antifungal agents enter the pipeline at Takeda

Xcellerate-based therapy shows promising results in otherwise untreatable cancer patients

HHS recommends first PI-sparing AIDS treatment regimen

New joint venture company will develop fullerene-based biopharmaceuticals

NexMed reports progress with development of ED therapeutic in China

Electroporation catheter safely and effectively delivers heparin to arterial wall

Hughes Institute studying BTK-specific inhibitor LFM-A13

Celtrix reports positive clinical results for SomatoKine; company seeks development partners

Fujisawa describes potential new agent for treating BPH

Major R&D agreement signed by two German companies

Eisai begins product launch of proton pump inhibitor in Germany

U.S. patent allowed for Vasogen's patient-specific therapy of autoimmune diseases

Preliminary report of therapeutic efficacy with 506U78 in leukemia patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...